BioVaxys Technology Corp.
BIOV
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -926.40K | -753.10K | -2.01M | -866.50K | -399.70K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 237.20K | -75.80K | 1.17M | 944.10K | 8.10K |
| Change in Net Operating Assets | 683.50K | 200.80K | 99.30K | -378.70K | 69.70K |
| Cash from Operations | -5.70K | -628.10K | -743.70K | -301.00K | -322.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -743.20K | -- | 0.00 | 0.00 | -778.50K |
| Cash from Investing | -743.20K | -- | 0.00 | 0.00 | -778.50K |
| Total Debt Issued | -- | -- | -13.80K | 13.80K | -- |
| Total Debt Repaid | -33.40K | -- | 0.00 | 0.00 | -33.40K |
| Issuance of Common Stock | 937.00K | 847.10K | 746.90K | 729.60K | 721.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 635.70K | 596.10K | 536.90K | 542.90K | 507.00K |
| Foreign Exchange rate Adjustments | 5.50K | -6.20K | 2.50K | -100.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Net Change in Cash | -107.70K | -38.30K | -204.40K | 241.80K | -593.50K |